Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.

about

Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.

Item

http://www.wikidata.org/entity/Q39456170

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Predictors of relapse and long ...... ome after rituximab treatment.

@en

Predictors of relapse and long ...... ome after rituximab treatment.

@nl

type

Item

label

Predictors of relapse and long ...... ome after rituximab treatment.

@en

Predictors of relapse and long ...... ome after rituximab treatment.

@nl

prefLabel

Predictors of relapse and long ...... ome after rituximab treatment.

@en

Predictors of relapse and long ...... ome after rituximab treatment.

@nl

P1476

Predictors of relapse and long ...... ome after rituximab treatment.

@en

P2093

Akifumi Yamada

http://www.w3.org/2001/XMLSchema#string

Akira Mizutani

http://www.w3.org/2001/XMLSchema#string

Daishi Hirano

http://www.w3.org/2001/XMLSchema#string

Koji Sakuraya

http://www.w3.org/2001/XMLSchema#string

Shuichiro Fujinaga

http://www.w3.org/2001/XMLSchema#string

Shunsuke Sakurai

http://www.w3.org/2001/XMLSchema#string

Toshiaki Shimizu

http://www.w3.org/2001/XMLSchema#string

P2860

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy.

Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.

Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.

Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome

Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.

B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome.

Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome.

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome.

P2888

s10157-016-1328-y

P304

671-676

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10157-016-1328-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27558467

http://www.w3.org/2001/XMLSchema#string